Detalhe da pesquisa
1.
Genome-wide and panel-based cell-free DNA characterization of patients with resectable esophageal adenocarcinoma.
J Pathol
; 261(3): 286-297, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37615198
2.
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer.
Gastric Cancer
; 25(5): 906-915, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35763187
3.
Cutaneous Toxicity After Chemoradiotherapy and PD-L1 Inhibition in Two Patients with Esophageal Adenocarcinoma: More than Meets the Eye.
Oncologist
; 24(4): e149-e153, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30902915
4.
Continuation of trastuzumab beyond progression in HER2-positive advanced esophagogastric cancer: a meta-analysis.
Acta Oncol
; 57(12): 1599-1604, 2018 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-30264641
5.
Gastro-oesophageal junction: to FLOT or to CROSS?
Acta Oncol
; 59(2): 233-236, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-31813320
6.
Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis.
Cell Rep Med
; 5(1): 101349, 2024 01 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38128532
7.
The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma.
Commun Med (Lond)
; 4(1): 89, 2024 May 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38760583
8.
High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy.
J Immunother Cancer
; 11(11)2023 11 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38016720
9.
Predictive value of radiological response, pathological response and relapse-free survival for overall survival in neoadjuvant immunotherapy trials: pooled analysis of 29 clinical trials.
Eur J Cancer
; 186: 211-221, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37062625
10.
Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition.
Oncoimmunology
; 12(1): 2233403, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37470057
11.
Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer.
Cell Rep Med
; 3(11): 100802, 2022 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36334593
12.
A systematic review of HER2 blockade for the curative treatment of gastroesophageal adenocarcinoma: Successes achieved and opportunities ahead.
Cancer Treat Rev
; 99: 102249, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34171733
13.
Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study.
Clin Cancer Res
; 27(13): 3784-3792, 2021 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33883174
14.
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT).
Clin Cancer Res
; 27(12): 3351-3359, 2021 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33504550
15.
Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types.
Biochim Biophys Acta Rev Cancer
; 1874(1): 188386, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32540465
16.
Immune Checkpoints as Promising Targets for the Treatment of Idiopathic Pulmonary Fibrosis?
J Clin Med
; 8(10)2019 Sep 26.
Artigo
Inglês
| MEDLINE | ID: mdl-31561518
17.
Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis.
Cancers (Basel)
; 11(4)2019 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31013858
18.
COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis.
Front Oncol
; 9: 684, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31403035
19.
The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysis.
Cancers (Basel)
; 11(1)2019 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30641964
20.
Chemotherapy and novel targeted therapies for operable esophageal and gastroesophageal junctional cancer.
Best Pract Res Clin Gastroenterol
; 36-37: 45-52, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30551856